Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675878 · ClinicalTrials.gov registry record · Phase 3
Confirmation of Diet as a Treatment for Gulf War Illness
A Phase 3 study of Gulf War Illness and Gulf War Syndrome, sponsored by American University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 3
- Study locations
NCT05675878: Recruiting Phase 3 study of Gulf War Illness and Gulf War Syndrome, sponsored by American University.
NCT05675878 is a Phase 3 study of Gulf War Illness and Gulf War Syndrome that is actively recruiting participants, run by American University. The registered enrollment target is 160 participants, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (36% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675878, a Phase 3 study of Gulf War Illness and Gulf War Syndrome, is actively recruiting participants, sponsored by American University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment response to the diet in a larger and more diverse group; 2) to examine how changes in the nervous system may be the reason for improvement; and 3) to identify markers which change in the blood after one month on the diet. Participants will have baseline measures collected and then will be randomized into the intervention or wait-listed control group, which they will follow for one month before being reassessed.
Conditions Studied
Interventions
- BEHAVIORAL Dietary Intervention
Study Locations (3)
District of Columbia
- American University - Washington D.C.
Florida
- Nova Southeastern University - Fort Lauderdale
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-12-30 |
| Phase | Phase 3 |
What NCT05675878 shows while recruiting
NCT05675878 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (36% higher).
The record links to 2 conditions, with Gulf War Illness appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.
NCT05675878 reports a single indexed study location in District of Columbia, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05675878 about?
NCT05675878 is a clinical study titled "Confirmation of Diet as a Treatment for Gulf War Illness". This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment...
What is the current status of trial NCT05675878?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2023-03-01. Estimated completion is 2025-12-30.
What conditions does trial NCT05675878 study?
This clinical trial studies the following conditions: Gulf War Illness, Gulf War Syndrome.
What interventions are being tested in trial NCT05675878?
The interventions under investigation include: Dietary Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05675878?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675878 being conducted?
This trial has 3 study locations across District of Columbia, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05675878's enrollment target sits among peer trials
160 4th of 14 higher than 11 of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Coenzyme Q10 Phase III Trial in Gulf War Illness
COMPLETED · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI